STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $33 | -79.0% | 8,440 | -43.1% | 0.00% | – |
| Q2 2023 | $157 | -17.4% | 14,829 | -35.1% | 0.00% | – |
| Q1 2023 | $190 | +11.8% | 22,860 | +23.9% | 0.00% | – |
| Q4 2022 | $170 | -99.9% | 18,443 | +74.6% | 0.00% | – |
| Q3 2022 | $135,000 | +3.1% | 10,563 | +6.5% | 0.00% | – |
| Q2 2022 | $131,000 | +33.7% | 9,921 | +111.8% | 0.00% | – |
| Q1 2022 | $98,000 | -91.2% | 4,685 | -89.9% | 0.00% | – |
| Q4 2021 | $1,112,000 | +377.3% | 46,338 | +405.4% | 0.00% | – |
| Q3 2021 | $233,000 | -37.0% | 9,169 | -16.7% | 0.00% | – |
| Q2 2021 | $370,000 | -46.1% | 11,013 | -37.6% | 0.00% | – |
| Q1 2021 | $686,000 | +115.7% | 17,647 | +243.8% | 0.00% | – |
| Q4 2020 | $318,000 | +38.9% | 5,133 | -24.7% | 0.00% | – |
| Q3 2020 | $229,000 | -4.2% | 6,815 | -31.7% | 0.00% | – |
| Q2 2020 | $239,000 | +68.3% | 9,981 | +61.0% | 0.00% | – |
| Q1 2020 | $142,000 | -48.9% | 6,198 | -37.0% | 0.00% | – |
| Q4 2019 | $278,000 | +115.5% | 9,836 | +63.9% | 0.00% | – |
| Q3 2019 | $129,000 | +377.8% | 6,001 | +556.6% | 0.00% | – |
| Q2 2019 | $27,000 | – | 914 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Skorpios Trust | 14,443,681 | $56,908,103 | 99.78% |
| Lynx1 Capital Management LP | 1,710,154 | $6,738,007 | 4.46% |
| COWEN AND COMPANY, LLC | 3,721,659 | $14,663,336 | 1.03% |
| Redmile Group, LLC | 3,872,696 | $15,258,422 | 0.73% |
| RTW INVESTMENTS, LP | 4,390,558 | $17,298,799 | 0.36% |
| Birchview Capital, LP | 85,000 | $334,900 | 0.28% |
| Cormorant Asset Management, LP | 1,087,807 | $4,285,960 | 0.25% |
| Granahan Investment Management | 851,201 | $3,353,732 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 348,069 | $1,371 | 0.12% |
| Simplify Asset Management Inc. | 102,985 | $405,761 | 0.05% |